Comparative guide · 5 min read

CoQ10 vs Magnesium for migraine prophylaxis — which one (or both)?

Updated 2026-05-18 · Reviewed by SupplementScore editors · No sponsorships

Both supplements carry AAN/American Headache Society Level B "probably effective" recommendations for migraine prevention, and both have a track record of running 8–12 weeks before delivering a noticeable reduction in attack frequency. In practice they fit different patients: CoQ10 fits the mitochondrial-energy phenotype (especially the patient with low energy, exertion-triggered headache, and statin co-prescription), while magnesium fits the menstrual-migraine and aura phenotype with greater consistency. Combining them at modest doses is common and reasonable.

Quick verdict

Migraine phenotypeBetter choiceWhy
Migraine with auraMagnesiumMost consistent benefit specifically in aura cohorts.
Menstrual-pattern migraineMagnesiumTrial signal in menstrual migraine; cycle-timed dosing in some protocols.
Migraine in patient on a statinCoQ10Statins lower endogenous CoQ10; replacement plausibly relevant.
Migraine in adolescentsCoQ10Pediatric/adolescent migraine has the cleanest CoQ10 RCT signal.
Migraine in pregnancyMagnesium (with clinician)Magnesium has the better pregnancy-safety record.
Migraine + constipation/leg cramps/sleep issuesMagnesiumCo-benefit on multiple complaints.
Migraine + fatigue / mitochondrial-disease phenotypeCoQ10 (ubiquinol)Mechanistic match; combined with B2 in some neurology protocols.
Cost-constrained patient, no special phenotypeMagnesium firstOne-tenth the cost; broader co-benefits.

How they compare on the things that matter

Mechanism — mitochondrial coenzyme vs cortical-excitability modulator

CoQ10 is an essential electron-transport-chain coenzyme. Migraine has well-documented mitochondrial features (reduced ATP, abnormal magnetic resonance spectroscopy in occipital cortex). CoQ10 supplementation aims to restore mitochondrial efficiency in the trigeminovascular system. Ubiquinol (the reduced form) is preferred for older adults and those with impaired conversion.

Magnesium has a different mechanism: it is a non-competitive NMDA-receptor antagonist (blocks cortical-spreading-depression initiation in aura), modulates calcium channels involved in vasoreactivity, and is a cofactor in serotonin biosynthesis. Magnesium deficiency is more common in chronic migraineurs than in matched controls — partly the basis for the AAN recommendation.

Evidence base by endpoint

Practical rule. If you're picking only one, magnesium is the first-line trial: cheaper, broader co-benefits, well-tolerated, and the migraine subtype that fits magnesium best (menstrual, aura) is common. Run 8–12 weeks with a headache diary. CoQ10 is the right next addition if magnesium produces partial response, particularly in patients on statins, with high-fatigue presentations, or adolescent migraineurs. Combining magnesium 400 mg + CoQ10 100–300 mg + riboflavin 400 mg is a well-tolerated stack with separate evidence for each component.

Dose and form

For magnesium, 400–600 mg/day of elemental magnesium. Glycinate, citrate, and L-threonate are the practical forms. Some specialists prefer magnesium oxide at 500 mg/day in trials, but its absorption is poor and the dose-response is reflected by laxative effect at higher doses. Trials have used both daily continuous dosing and menstrual-cycle-targeted protocols.

For CoQ10, 100 mg t.i.d. (300 mg/day) of ubiquinol is the dose with the cleanest trial signal in adult migraine. Pediatric protocols typically use 1–3 mg/kg/day. Ubiquinol is better absorbed than ubiquinone in older adults; for younger adults with no malabsorption, the difference is smaller.

Safety

Magnesium is well-tolerated; loose stools are the practical dose-limit. Cautions are renal insufficiency (eGFR <30) and additive effects with certain antihypertensives.

CoQ10 is well-tolerated. Theoretical interactions include reduced effect of warfarin (CoQ10 is structurally similar to vitamin K and can lower INR), and reduced effect of some chemotherapies. Discontinue 2 weeks before scheduled surgery as a precaution.

What the price difference buys you

Magnesium glycinate at 400 mg elemental runs $0.10–0.25/day. CoQ10 ubiquinol at 300 mg/day runs $1.00–2.50/day. Per dollar of trial-supported migraine prevention, magnesium has a clear edge — particularly because it offers significant co-benefits (sleep, leg cramps, constipation) that CoQ10 does not.

What we'd actually buy

For most migraineurs starting a prophylactic stack: magnesium glycinate 400 mg elemental at bedtime + riboflavin (vitamin B2) 400 mg with breakfast. Run 8–12 weeks with a written headache diary. Both are AAN/AHS Level B recommendations, are well-tolerated, and stack well.

For migraineurs with partial response to that stack — particularly statin users, high-fatigue presentations, or adolescent patients — add ubiquinol CoQ10 100 mg three times daily. The full stack of magnesium + riboflavin + CoQ10 is well-established in headache-clinic practice as the supplement layer before escalating to prescription preventatives (topiramate, propranolol, CGRP monoclonals).

Sources

Read more: